Pfizer Inc. (FRA:PFE)
20.32
-0.17 (-0.81%)
Sep 25, 2025, 8:21 PM CET
Pfizer Employees
Pfizer had 81,000 employees as of December 31, 2024. The number of employees decreased by 7,000 or -7.95% compared to the previous year.
Employees
81,000
Change (1Y)
-7,000
Growth (1Y)
-7.95%
Revenue / Employee
€672,611
Profits / Employee
€113,294
Market Cap
116.63B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 81,000 | -7,000 | -7.95% |
Dec 31, 2023 | 88,000 | 5,000 | 6.02% |
Dec 31, 2022 | 83,000 | 4,000 | 5.06% |
Dec 31, 2021 | 79,000 | 500 | 0.64% |
Dec 31, 2020 | 78,500 | -9,800 | -11.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Sartorius Aktiengesellschaft | 13,528 |
Fresenius Medical Care AG | 111,513 |
Fielmann Group AG | 24,363 |
Carl Zeiss Meditec AG | 5,730 |
Pfizer News
- 1 day ago - Should You Forget Pfizer and Buy These Unstoppable Stocks Instead? - The Motley Fool
- 1 day ago - Where Will Pfizer Be in 5 Years? - The Motley Fool
- 1 day ago - Time to Buy Pfizer (PFE) or Metsera (MTSR) Stock? - Nasdaq
- 1 day ago - METSERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Metsera, Inc. - MTSR - Business Wire
- 2 days ago - Can PFE Successfully Return to the Obesity Space With Metsera Buyout? - Nasdaq
- 2 days ago - PFE Quantitative Stock Analysis - Nasdaq
- 2 days ago - Pfizer Invites Public to View and Listen to Webcast of November 4 Conference Call with Analysts - Wallstreet:Online
- 2 days ago - Pfizer Invites Public to View and Listen to Webcast of November 4 Conference Call with Analysts - Business Wire